Sachpekidis, C., Haberkorn, U., & Hassel, J. C. (2015). Predictive value of early F-18-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: Preliminary results of an ongoing study. European journal of nuclear medicine and molecular imaging, 42(3), . https://doi.org/10.1007/s00259-014-2944-y
Chicago Style (17th ed.) CitationSachpekidis, Christos, Uwe Haberkorn, and Jessica C. Hassel. "Predictive Value of Early F-18-FDG PET/CT Studies for Treatment Response Evaluation to Ipilimumab in Metastatic Melanoma: Preliminary Results of an Ongoing Study." European Journal of Nuclear Medicine and Molecular Imaging 42, no. 3 (2015). https://doi.org/10.1007/s00259-014-2944-y.
MLA (9th ed.) CitationSachpekidis, Christos, et al. "Predictive Value of Early F-18-FDG PET/CT Studies for Treatment Response Evaluation to Ipilimumab in Metastatic Melanoma: Preliminary Results of an Ongoing Study." European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 3, 2015, https://doi.org/10.1007/s00259-014-2944-y.